Market Overview:
The global indomethacin market is expected to grow at a CAGR of 3.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of arthritis, increasing awareness about the benefits of indomethacin and technological advancements in the field of drug delivery. However, patent expiry of key drugs and stringent regulatory requirements are some factors that are likely to restrain the growth of this market during the forecast period. On basis on type, Indomethacin Tablet dominates global Indomethacin Market with more than 60% share by volume in 2017; whereas Capsule form is projected to grow at highest CAGR over next 10 years owing its advantages over tablet form including patient compliance and dosage accuracy etc.
Product Definition:
It is a nonsteroidal anti-inflammatory drug used to treat pain, inflammation, and fever. It inhibits the production of prostaglandins, which are chemicals that contribute to inflammation.
Indomethacin Tablet:
Indomethacin tablet is a type of medication used to treat several medical conditions such as arthritis, inflammation, and fever. It works by reducing the production of cytokines (substances that trigger inflammation) in the body. The global indomethacin market is expected to witness significant growth over the forecast period owing to increasing incidences of chronic diseases like rheumatoid arthritis and osteoarthritis globally.
Indomethacin Capsule:
Indomethacin capsule is a type of medication used to treat several medical conditions such as arthritis, inflammation, and pain. It works by reducing the production of cytokines (substances that trigger inflammation) and prostaglandins (inflammatory substances). As a result, it reduces the swelling and pain associated with rheumatoid arthritis. Furthermore, it is also used to reduce fever in patients suffering from malaria or HIV/AIDS-related complex.
Application Insights:
Indomethacin is used for the treatment of various diseases in children and adults. In 2016, the application segment was dominated by Indomethacin Capsule with a share of over 80.0% in that year. The other applications include suppository form (used for pain management) and tablets form (used as an anti-inflammatory agent).
The use of indomethacin capsules as an anti-inflammatory drug has been approved by the U.S FDA under category III for treating sprains, strains and arthritis in dogs weighing less than 25 pounds; however, this usage is not common due to availability of alternative drugs with better safety profiles under that weight limit such as phenylbutazone or flunixine hydrochloride among others [1].
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to maintain its position through the forecast period owing to high product demand from countries, such as India and China. In addition, increasing prevalence of joint-related disorders coupled with rising geriatric population in this region is anticipated to drive the market growth over the forecast period.
Europe accounted for a significant share of revenue in 2017 due to growing consumer awareness regarding health and well-being along with an increase in spending capacity among individuals living there. Moreover, presence of major manufacturers including GlaxoSmithKline plc., FrieslandCampina Groep Nv., Bayer AG will also help boost regional product sales over the coming years.
North America held a considerable share owing to high consumption levels coupled with favorable reimbursement scenario observed within U.S & Canada for osteoarthritis treatment options leading brands like Pfizer Inc.'s Celebrex and Merck & Co.
Growth Factors:
- Increasing incidence of chronic diseases such as arthritis, rheumatoid arthritis, and osteoarthritis which can be treated with Indomethacin.
- Growing awareness about the benefits of Indomethacin in the treatment of chronic diseases.
- Rising demand for pain relief medications across the globe.
- Availability of generic versions of Indomethacin that offer lower prices compared to branded drugs.
Scope Of The Report
Report Attributes
Report Details
Report Title
Indomethacin Market Research Report
By Type
Indomethacin Tablet, Indomethacin Capsule, Indomethacin Suppository, Other
By Application
Children, Adults
By Companies
Xinhua Pharma, Hotai Pharma, Konch Pharma, Ouyi Pharma, ...
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Indomethacin Market Report Segments:
The global Indomethacin market is segmented on the basis of:
Types
Indomethacin Tablet, Indomethacin Capsule, Indomethacin Suppository, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Children, Adults
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Xinhua Pharma
- Hotai Pharma
- Konch Pharma
- Ouyi Pharma
- ...
Highlights of The Indomethacin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Indomethacin Tablet
- Indomethacin Capsule
- Indomethacin Suppository
- Other
- By Application:
- Children
- Adults
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Indomethacin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Indomethacin is a medication used to treat pain and inflammation. It is also used to reduce fever.
Some of the key players operating in the indomethacin market are Xinhua Pharma, Hotai Pharma, Konch Pharma, Ouyi Pharma.
The indomethacin market is expected to grow at a compound annual growth rate of 3.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Indomethacin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Indomethacin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Indomethacin Market - Supply Chain
4.5. Global Indomethacin Market Forecast
4.5.1. Indomethacin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Indomethacin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Indomethacin Market Absolute $ Opportunity
5. Global Indomethacin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Indomethacin Market Size and Volume Forecast by Type
5.3.1. Indomethacin Tablet
5.3.2. Indomethacin Capsule
5.3.3. Indomethacin Suppository
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Indomethacin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Indomethacin Market Size and Volume Forecast by Application
6.3.1. Children
6.3.2. Adults
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Indomethacin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Indomethacin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Indomethacin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Indomethacin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Indomethacin Demand Share Forecast, 2019-2029
9. North America Indomethacin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Indomethacin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Indomethacin Market Size and Volume Forecast by Application
9.4.1. Children
9.4.2. Adults
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Indomethacin Market Size and Volume Forecast by Type
9.7.1. Indomethacin Tablet
9.7.2. Indomethacin Capsule
9.7.3. Indomethacin Suppository
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Indomethacin Demand Share Forecast, 2019-2029
10. Latin America Indomethacin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Indomethacin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Indomethacin Market Size and Volume Forecast by Application
10.4.1. Children
10.4.2. Adults
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Indomethacin Market Size and Volume Forecast by Type
10.7.1. Indomethacin Tablet
10.7.2. Indomethacin Capsule
10.7.3. Indomethacin Suppository
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Indomethacin Demand Share Forecast, 2019-2029
11. Europe Indomethacin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Indomethacin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Indomethacin Market Size and Volume Forecast by Application
11.4.1. Children
11.4.2. Adults
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Indomethacin Market Size and Volume Forecast by Type
11.7.1. Indomethacin Tablet
11.7.2. Indomethacin Capsule
11.7.3. Indomethacin Suppository
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractivenss/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Indomethacin Demand Share, 2019-2029
12. Asia Pacific Indomethacin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Indomethacin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Indomethacin Market Size and Volume Forecast by Application
12.4.1. Children
12.4.2. Adults
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Indomethacin Market Size and Volume Forecast by Type
12.7.1. Indomethacin Tablet
12.7.2. Indomethacin Capsule
12.7.3. Indomethacin Suppository
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Indomethacin Demand Share, 2019-2029
13. Middle East & Africa Indomethacin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Indomethacin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Indomethacin Market Size and Volume Forecast by Application
13.4.1. Children
13.4.2. Adults
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Indomethacin Market Size and Volume Forecast by Type
13.7.1. Indomethacin Tablet
13.7.2. Indomethacin Capsule
13.7.3. Indomethacin Suppository
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Indomethacin Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Indomethacin Market: Market Share Analysis
14.2. Indomethacin Distributors and Customers
14.3. Indomethacin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Xinhua Pharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Hotai Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Konch Pharma
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Ouyi Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ...
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
